ADMINISTRATIVE CORE
ADMINISTRATIVE CORE
批准号:
10675457
负责人:
HUDA Y ZOGHBI
金额:
$17.65万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-22 至 2025-05-31
关键词:
Basic ScienceCellsClinicalClinical TrialsCollaborationsCommunicationCommunitiesCore FacilityDedicationsDevelopmentDiagnosticDiseaseEducationEnsureFosteringFundingFutureGene DosageGeneticGoalsHumanIndividualInfluentialsInstitutionInstitutional Review BoardsIntellectual and Developmental Disabilities Research CentersInternationalInvestigationKnowledgeLaboratoriesLeadershipMeasuresMedicineMissionMolecularMonitorOligonucleotidesOutcomeParticipantPathogenesisPersonsPlayPopulationPublicationsReproducibilityResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesRoleServicesStudy modelsTherapeutic InterventionTissuesTrainingWorkanimal model developmentbaseclinical translationclinical trial readinesscollegecommunity partnershipcost effectivedesigneducation planningfaculty researchfaculty supportgene therapyimprovedinnovationinvestigator trainingmultidisciplinarynext generationnovel diagnosticsnovel therapeutic interventionpre-clinicalpreclinical studyprogramsrecruitspecific biomarkerssynergismtherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Administrative Core supports the mission of the Eunice Kennedy Shriver Intellectual and Developmental
Disabilities Research Center at Baylor College of Medicine (BCM IDDRC) to identify as many causes of IDD as
possible, to understand their pathogenesis, and to develop novel diagnostic and therapeutic approaches by
providing oversight and management of the activities of the entire Center, disseminating information about
advancements and coordinating collaborative efforts with researchers in the IDDRC network and around the
world. Dr. Huda Zoghbi has served as the Center Director for more than 25 years and is joined by Drs. David
Nelson and Rodney Samaco to form the Executive Team of the Administrative Core. The Executive Team is
dedicated to ensuring that the BCM IDDRC is a most innovative and efficient Center. The overarching goal of
the Administrative Core is to enhance IDD research activities at BCM by encouraging and fostering local and
collaborative research efforts, the development of therapies to treat IDD, attracting and training investigators to
enhance the workforce in IDD research and disseminating information through engagement, communication and
education of stakeholders. This Core will support faculty research into IDD through provision of strategic
core facilities and by developing new core services as fields advance. All research projects are proposed
for use of the Administrative Core. This Core helps align core services to the overall mission of the Center, works
with the Core Directors to monitor and ensure that the services provided are high-quality and cost-effective, and
ensures that the Core services capitalize on existing resources and institutional support from BCM. The core will
also support translational efforts in IDD through the Clinical Translational Core, designed to assist investigators
with designing and carrying out human research including IRB approval, acquisition of biospecimens, diagnostic
studies, and therapeutic interventions for people with IDD and a multidisciplinary signature research project
that will lead to clinical trial readiness, developing biomarkers specific and sensitive to altered gene dosage. In
order to promote and enhance collaborative efforts and dissemination of knowledge, the Core proposes
a plan for engagement, communication, and education (ECE), extending the reach of the Center’s activities
to stakeholders at the local, state, and national levels. The ECE will implement best practices for community
partnerships building on and extending existing community relationships to ensure ongoing bi-directional
communication, inform investigators and the community of questions/concerns by each group, ensure successful
recruitment and retention of study participants, and determine feasibility of future studies in this population. The
Administrative Core recognizes the importance of broad collaborations, especially with the IDDRC network and
will continue to contribute to and collaborate with all network activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADMINISTRATIVE CORE
-
批准号:10427278
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2020
-
负责人:HUDA Y ZOGHBI
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:10221023
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2020
-
负责人:HUDA Y ZOGHBI
-
依托单位:
CORE D1: Neuropathology
-
批准号:8318647
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2011
-
负责人:HUDA Y ZOGHBI
-
依托单位:
NRI Build-out: Advancing Translational Brain Research
-
批准号:7875553
-
项目类别:
-
资助金额:$1489.53万
-
财政年份:2010
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Elucidating the Roles of SHANK3 and FXR in the Autism Interactome
-
批准号:7842983
-
项目类别:
-
资助金额:$40.35万
-
财政年份:2009
-
负责人:HUDA Y ZOGHBI
-
依托单位:
CORE D1: Neuropathology
-
批准号:7759248
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2009
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Baylor Intellectual and Developmental Disabilities Research Center
-
批准号:7931284
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2009
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:7435317
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:8236446
-
项目类别:
-
资助金额:$34.41万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:9264030
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:9905561
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:7869120
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROME
-
批准号:10614600
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROME
-
批准号:10295642
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:7138727
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:7825406
-
项目类别:
-
资助金额:$36.05万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:9174433
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROME
-
批准号:10428662
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:8535217
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
Molecular Pathogenesis Studies of Rett Syndrome
-
批准号:7283748
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2006
-
负责人:HUDA Y ZOGHBI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: